A Pilot Study on Raltegravir, Tenofovir and Emtricitabine for Peri-exposure Prophylaxis for HIV Infection (PERIEP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01697046
Recruitment Status : Unknown
Verified September 2012 by Mauro Schechter, Projeto Praça Onze.
Recruitment status was:  Not yet recruiting
First Posted : October 2, 2012
Last Update Posted : October 2, 2012
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Mauro Schechter, Projeto Praça Onze

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : March 2014
  Estimated Study Completion Date : March 2014